💊
Ogli
Tablet
Generic Name
Pioglitazone
Manufacturer
Kemiko Pharmaceuticals Ltd.
Unit Price
Unit Price: ৳ 8.03 (30's pack: ৳ 240.90)
🔹 Indications
Ogli is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Ogli is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.
🔹 Pharmacology
Ogli is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Ogli is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.
🔹 Dosage & Administration
Ogli is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Ogli is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.
🔹 Interaction
Ogli is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Ogli is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.
🔹 Contraindications
Ogli is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Ogli is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.
🔹 Side Effects
Ogli is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Ogli is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.
🔹 Pregnancy & Lactation
Ogli is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Ogli is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.
🔹 Precautions & Warnings
Ogli is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Ogli is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.
🔹 Storage Conditions
Ogli is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Ogli is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.
💡 Frequently Asked Questions
Ogli is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Ogli is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when die...
Ogli is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Ogli is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when die...
Ogli is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Ogli is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when die...
User Reviews
⭐
No reviews yet!
Be the first to share your experience.